Intelligent Control with Artificial Neural Networks for Automated Insulin Delivery Systems
Type 1 diabetes <i>mellitus</i> is a disease that affects millions of people around the world. Recent progress in embedded devices has allowed the development of artificial pancreas that can pump insulin subcutaneously to automatically regulate blood glucose levels in diabetic patients....
Main Authors: | João Lucas Correia Barbosa de Farias, Wallace Moreira Bessa |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Bioengineering |
Subjects: | |
Online Access: | https://www.mdpi.com/2306-5354/9/11/664 |
Similar Items
-
Open source automated insulin delivery systems: benefits, limitations and challenges in diabetes care
by: K. S. Shishin, et al.
Published: (2023-08-01) -
Open source automated insulin delivery systems: experience of russian patients
by: V. V. Klimontov, et al.
Published: (2023-12-01) -
Diabetes technology including automated insulin delivery systems to manage hyperglycemia in a failing pancreatic graft: Case series of people with type 1 diabetes and a pancreas kidney or pancreas‐only transplant
by: Dimitra Stathi, et al.
Published: (2023-07-01) -
The changing landscape of automated insulin delivery in the management of type 1 diabetes
by: Rama Lakshman, et al.
Published: (2023-08-01) -
Closed-loop insulin delivery in pregnant women with type 1 diabetes (CRISTAL): a multicentre randomized controlled trial – study protocol
by: Kaat Beunen, et al.
Published: (2023-03-01)